{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:00:44Z","timestamp":1791046844010,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.blre.2005.01.007","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T12:06:54Z","timestamp":1112962014000},"page":"15-27","source":"Crossref","is-referenced-by-count":126,"title":["Chronic graft-versus-host disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Mitchell E.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2005.01.007_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0065-2776(08)60549-0","article-title":"Graft-versus-host reactions: a review","volume":"22","author":"Grebe","year":"1976","journal-title":"Adv Immunol"},{"key":"10.1016\/j.blre.2005.01.007_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM196510282731803","article-title":"Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease","volume":"273","author":"Hathaway","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007890-198204000-00010","article-title":"Chronic graft-versus-host disease in the rat radiation chimera. I. Clinical features, hematology, histology, and immunopathology in long-term chimeras","volume":"33","author":"Beschorner","year":"1982","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00007890-198211000-00010","article-title":"Chronic graft-versus-host disease in the rat radiation chimera. II. Immunological evaluation in long-term chimera","volume":"34","author":"Tutschka","year":"1982","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood.V59.5.1073.1073","article-title":"Low serum thymic hormone levels in patients with chronic graft-versus-host disease","volume":"59","author":"Atkinson","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib6","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V97.5.1458","article-title":"Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Weinberg","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197905103001901","article-title":"Aberrations of suppressor T cells in human graft-versus-host disease","volume":"300","author":"Reinherz","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib8","first-page":"479","article-title":"Autoimmunity in chronic graft-versus-host disease","volume":"13","author":"Fialkow","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2005.01.007_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-9343(79)91171-9","article-title":"Chronic graft versus host disease: a syndrome of disordered immunity","volume":"66","author":"Graze","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib10","first-page":"19","article-title":"Autoantibody analysis of patients with graft-versus-host disease","volume":"24","author":"Lister","year":"1987","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.blre.2005.01.007_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00007890-198808000-00010","article-title":"Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients","volume":"46","author":"Rouquette-Gally","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.1987.tb02351.x","article-title":"High levels of anti-cytoskeleton autoantibodies are frequently associated with chronic GVHD","volume":"67","author":"Dighiero","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib13","first-page":"93","article-title":"Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies","volume":"6","author":"Kier","year":"1990","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V79.4.1081.bloodjournal7941081","article-title":"Nucleolar proteins B23 and C23 as target antigens in chronic graft-versus-host disease","volume":"79","author":"Wesierska-Gadek","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-2133.1996.tb06314.x","article-title":"Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association","volume":"134","author":"Bell","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.blre.2005.01.007_bib16","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2005.01.007_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1600-0609.2001.00331.x","article-title":"An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation","volume":"66","author":"Remberger","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1083-8791(00)70029-2","article-title":"De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival","volume":"6","author":"Wagner","year":"2000","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/bbmt.2002.v8.abbmt080674","article-title":"Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Remberger","year":"2002","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V86.3.1228.1228","article-title":"The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone","volume":"86","author":"Nademanee","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib21","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1704228","article-title":"The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis","volume":"32","author":"Ho","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib23","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2004.06.102","article-title":"Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: A study from the acute leukemia working party of the European group for Blood and Marrow Transplantation","volume":"22","author":"Ringden","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2005.01.007_bib24","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood.V96.8.2703","article-title":"Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation","volume":"96","author":"Thomson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib25","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","article-title":"CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation","volume":"98","author":"Zaucha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib26","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794","article-title":"Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation","volume":"88","author":"Bensinger","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2141.1996.d01-1958.x","article-title":"Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors","volume":"95","author":"Schmitz","year":"1996","journal-title":"Brit J Haem"},{"key":"10.1016\/j.blre.2005.01.007_bib28","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1182\/blood.V90.12.4705","article-title":"Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease","volume":"90","author":"Storek","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib29","first-page":"555","article-title":"High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies","volume":"17","author":"Majolino","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib30","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib31","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation","volume":"98","author":"Przepiorka","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib32","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"Korbling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib33","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood.V100.9.3128","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study","volume":"100","author":"Mohty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib34","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","article-title":"Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis","volume":"19","author":"Cutler","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2005.01.007_bib35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.1996.tb06991.x","article-title":"Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease","volume":"134","author":"Nagler","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.blre.2005.01.007_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00007890-198609000-00022","article-title":"Development of bullous pemphigoid after allogeneic bone marrow transplantation. Report of a case","volume":"42","author":"Ueda","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00007890-198601000-00029","article-title":"Chronic graft-versus-host disease complicated by micronodular cirrhosis and esophageal varices","volume":"41","author":"Yau","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib39","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(80)91621-9","article-title":"Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease","volume":"1","author":"Epstein","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2005.01.007_bib40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0360-3016(94)00392-X","article-title":"Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation","volume":"32","author":"Benyunes","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.blre.2005.01.007_bib41","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archinte.144.8.1591","article-title":"Oral manifestations of chronic graft-v-host disease","volume":"144","author":"Schubert","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2005.01.007_bib42","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00007890-199212000-00012","article-title":"A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation","volume":"54","author":"Schwarer","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib43","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.bmt.1702429","article-title":"Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome","volume":"25","author":"Duncker","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-107-5-648","article-title":"Risk factors for airflow obstruction in recipients of bone marrow transplants","volume":"107","author":"Clark","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2005.01.007_bib45","first-page":"51","article-title":"Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories","volume":"21","author":"Sullivan","year":"1989","journal-title":"Transpl Proc"},{"key":"10.1016\/j.blre.2005.01.007_bib46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood.V72.2.621.621","article-title":"Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG","volume":"72","author":"Holland","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1083-8791(03)00242-8","article-title":"Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes","volume":"9","author":"Dudek","year":"2003","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib48","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(81)90059-7","article-title":"Esophageal abnormalities in chronic graft-versus-host disease in humans","volume":"80","author":"McDonald","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.blre.2005.01.007_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2214\/ajr.142.3.501","article-title":"Radiographic features of esophageal involvement in chronic graft-versus-host disease","volume":"142","author":"McDonald","year":"1984","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.blre.2005.01.007_bib50","first-page":"488","article-title":"Gynecologic manifestations of chronic graft-versus-host disease","volume":"60","author":"Corson","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2005.01.007_bib51","first-page":"425","article-title":"Gynecological abnormalities following allogeneic bone marrow transplantation","volume":"5","author":"Schubert","year":"1990","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib52","first-page":"207","article-title":"Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease","volume":"17","author":"Seber","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib53","first-page":"279","article-title":"Poor graft function associated with graft-versus-host disease after allogeneic marrow transplantation","volume":"2","author":"Peralvo","year":"1987","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib54","first-page":"357","article-title":"Renal involvement in chronic graft-versus-host disease: a report of two cases","volume":"3","author":"Gomez-Garcia","year":"1988","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.1996.14.2.579","article-title":"Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease","volume":"14","author":"Miralbell","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2005.01.007_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/stem.5530040306","article-title":"Hemopoietic progenitor cell function after HLA-identical sibling bone marrow transplantation: influence of chronic graft-versus-host disease","volume":"4","author":"Atkinson","year":"1986","journal-title":"Int J Cell Cloning"},{"key":"10.1016\/j.blre.2005.01.007_bib57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood.V73.4.1054.1054","article-title":"Graft-v-host disease is associated with autoimmune-like thrombocytopenia","volume":"73","author":"Anasetti","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1700746","article-title":"De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant","volume":"19","author":"Godder","year":"1997","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-133-4-200008150-00011","article-title":"Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease","volume":"133","author":"Ratanatharathorn","year":"2000","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2005.01.007_bib60","first-page":"53","article-title":"Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation","volume":"97","author":"Siadak","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2005.01.007_bib61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ajh.2830450309","article-title":"Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease","volume":"45","author":"Seidler","year":"1994","journal-title":"Amer J Hematol"},{"key":"10.1016\/j.blre.2005.01.007_bib62","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.1994.tb04795.x","article-title":"Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors","volume":"86","author":"Socie","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","article-title":"Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study","volume":"7","author":"Stern","year":"2001","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib64","first-page":"665","article-title":"Effects of chronic graft-versus-host disease on growth and development","volume":"vol. 37","author":"Sanders","year":"1990"},{"key":"10.1016\/j.blre.2005.01.007_bib65","series-title":"Graft-versus-host disease: immunology, pathphysiology, and treatment","first-page":"631","article-title":"Early detection and monitoring of chronic graft-versus-host disease","author":"Loughran","year":"1990"},{"key":"10.1016\/j.blre.2005.01.007_bib66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib67","first-page":"247","article-title":"Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry","volume":"4","author":"Atkinson","year":"1989","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib68","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood.V97.5.1219","article-title":"Development of a prognostic model for grading chronic graft-versus-host disease","volume":"97","author":"Akpek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood-2002-10-3141","article-title":"Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study","volume":"102","author":"Akpek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib70","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood.V76.1.228.228","article-title":"Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"76","author":"Loughran","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1701313","article-title":"The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation","volume":"22","author":"Wagner","year":"1998","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bmt.1703278","article-title":"Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease","volume":"28","author":"Jacobsohn","year":"2001","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib74","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia.","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199002223220801","article-title":"Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors","volume":"322","author":"Ash","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib76","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib77","first-page":"44","article-title":"A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery","volume":"2","author":"Sullivan","year":"1996","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib78","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2003.04228.x","article-title":"T-cell depletion with Campath-1H \u2018in the bag\u2019 for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival","volume":"121","author":"Chakrabarti","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood.V79.1.269.269","article-title":"Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome","volume":"79","author":"Gluckman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-0012.1987.tb00685.x","article-title":"Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophlaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation","volume":"1","author":"Santos","year":"1987","journal-title":"Clin Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.1989.tb04325.x","article-title":"Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial","volume":"72","author":"Storb","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib83","first-page":"491","article-title":"Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treament with corticosteroids","volume":"20","author":"Ruutu","year":"1988","journal-title":"Tranpl Proc"},{"key":"10.1016\/j.blre.2005.01.007_bib84","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1990.tb06356.x","article-title":"Long-term cyclosporin therapy may decrease the risk of chronic graft-versus-host disease","volume":"74","author":"Lonnquist","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib85","first-page":"341","article-title":"Cyclosporin A and chronic graft versus host disease","volume":"6","author":"Bacigalupo","year":"1990","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib86","first-page":"194","article-title":"Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?","volume":"3","author":"Storb","year":"1997","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib87","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood.V98.13.3868","article-title":"Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial","volume":"98","author":"Kansu","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib88","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0268-960X(94)90076-T","article-title":"The management of chronic graft-versus-host disease","volume":"8","author":"Siadak","year":"1994","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2005.01.007_bib89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib90","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib91","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2005.01.007_bib92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/bbmt.2001.v7.pm11400948","article-title":"Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease","volume":"7","author":"Arora","year":"2001","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib93","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V96.12.3995","article-title":"Thalidomide for treatment of patients with chronic graft-versus-host disease","volume":"96","author":"Koc","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib94","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbmt.2003.08.001","article-title":"Graft-versus-host disease of the vulva and\/or vagina: diagnosis and treatment","volume":"9","author":"Spiryda","year":"2003","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib95","first-page":"466","article-title":"Long-term efficacy and safety of topical tacrolimus in the management of ulcerative\/erosive oral lichen planus","volume":"13","author":"Hodgson","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.blre.2005.01.007_bib96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.bmt.1701304","article-title":"The use of topical cyclosporin A in ocular graft-versus-host disease","volume":"22","author":"Kiang","year":"1998","journal-title":"Bone Marrow Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2005.01.007_bib97","first-page":"127","article-title":"Late complications of allogeneic and autologous marrow transplantation","volume":"10","author":"Sullivan","year":"1992","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib98","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bmt.1701936","article-title":"Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus","volume":"24","author":"Mookerjee","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib99","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1083-8791(00)70026-7","article-title":"Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease","volume":"6","author":"Carnevale-Schianca","year":"2000","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1702626","article-title":"Response to thalidomide therapy in refractory chronic graft-versus-host disease","volume":"26","author":"Browne","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib101","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/blood.V86.9.3604.bloodjournal8693604","article-title":"Thalidomide as salvage therapy for chronic graft-versus-host disease","volume":"86","author":"Parker","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib102","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood.V89.7.2298","article-title":"Treatment of chronic graft-versus-host disease with clofazimine","volume":"89","author":"Lee","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib103","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00007890-199011000-00013","article-title":"8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease","volume":"50","author":"Eppinger","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib104","first-page":"151","article-title":"Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation","volume":"18","author":"Deeg","year":"1992","journal-title":"Blood Cells"},{"key":"10.1016\/j.blre.2005.01.007_bib105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00007890-199501150-00030","article-title":"Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients","volume":"59","author":"Aubin","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib106","first-page":"1061","article-title":"Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA)","volume":"17","author":"Vogelsang","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib107","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007890-199402000-00015","article-title":"Immunomodulation with photopheresis: clinical results of the multi-center cardiac transplantation study: reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation","volume":"57","author":"Barr","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib108","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1526-0968.2002.00448.x","article-title":"Extracorporeal photochemotherapy for the treatment of graft-versus-host disease","volume":"6","author":"Dall\u2019Amico","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.blre.2005.01.007_bib109","first-page":"845","article-title":"Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis","volume":"14","author":"Owsianowski","year":"1994","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00007890-199501150-00029","article-title":"Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease","volume":"59","author":"Rossetti","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1083-8791(98)90007-6","article-title":"Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease","volume":"4","author":"Smith","year":"1998","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib112","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V92.9.3098","article-title":"Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease","volume":"92","author":"Greinix","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib113","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0006-2952(96)00427-3","article-title":"Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone","volume":"52","author":"Halevy","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.blre.2005.01.007_bib114","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/00007890-199912150-00027","article-title":"Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis","volume":"68","author":"Nagler","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/blood.V93.1.66","article-title":"Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease","volume":"93","author":"Marcellus","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib116","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1365-2141.2001.02582.x","article-title":"Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab","volume":"112","author":"Willenbacher","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib117","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007890-200202270-00035","article-title":"Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease","volume":"73","author":"Chiang","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2005.01.007_bib118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bmt.1701281","article-title":"Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients","volume":"22","author":"Basara","year":"1998","journal-title":"Bone Marrow Transpl"},{"issue":"suppl","key":"10.1016\/j.blre.2005.01.007_bib119","first-page":"398a","article-title":"Efficacy of mycophenolate mofetil (MMF) in the treatment of chronic graft-versus-host disease","volume":"98","author":"Lopez","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2005.01.007_bib120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1083-8791(00)70058-9","article-title":"Hydroxychloroquine for the treatment of chronic graft-versus-host disease","volume":"6","author":"Gilman","year":"2000","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib121","first-page":"641","article-title":"Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease","volume":"18","author":"Murphy","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib122","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/10428199709055591","article-title":"Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies","volume":"24","author":"Singhal","year":"1997","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.blre.2005.01.007_bib123","first-page":"145","article-title":"Neuropharamacologic therapy of the neuromuscular manifestations of graft-versus-host disease","volume":"6","author":"Adams","year":"1987","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.blre.2005.01.007_bib124","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7326\/0003-4819-116-8-624","article-title":"Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver","volume":"116","author":"Fried","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2005.01.007_bib125","first-page":"395","article-title":"Bone density loss during treatment of chronic GVHD","volume":"17","author":"Stern","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.blre.2005.01.007_bib126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S8756-3282(97)00219-6","article-title":"Avascular necrosis following bone marrow transplantation: a case-control study","volume":"22","author":"Fink","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.blre.2005.01.007_bib127","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1182\/blood.V95.12.3683","article-title":"Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants","volume":"95","author":"Kulkarni","year":"2000","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2005.01.007_bib128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/stem.5530040712","article-title":"Early and late interstitial pneumonia following human bone marrow transplantation","volume":"4","author":"Sullivan","year":"1986","journal-title":"Int J Cell Cloning"},{"key":"10.1016\/j.blre.2005.01.007_bib129","doi-asserted-by":"crossref","unstructured":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6:659\u2013713.","DOI":"10.1016\/S1083-8791(00)70001-2"},{"key":"10.1016\/j.blre.2005.01.007_bib130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.2001.03135.x","article-title":"Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients","volume":"115","author":"Maury","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2005.01.007_bib131","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/archinte.143.9.1735","article-title":"Pneumococcal vaccination of recipients of bone marrow transplants","volume":"143","author":"Winston","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2005.01.007_bib132","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","article-title":"Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine","volume":"159","author":"Ljungman","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2005.01.007_bib133","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2005.01.007_bib134","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X05000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X05000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T09:43:55Z","timestamp":1735638235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X05000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0268960X05000081"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2005.01.007","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}